This article explores how automation is transforming proteomics by streamlining proteoform analysis, boosting throughput and ...

For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...

The global luciferase assay market is set to experience robust growth, with its valuation projected to rise from USD 1,536.70 million in 2024 to USD 3,022.90 million by 2034, registering a CAGR of ...

Laboratoire de Spectrométrie de Masse BioOrganique, CNRS, Université de Strasbourg, IPHC UMR 7178, Infrastructure Nationale de Protéomique ProFI - FR2048, 67087 Strasbourg, France ...

Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening ...

In a first, scientists have identified promising drug candidates that can permanently disable a key cancer protein once deemed untreatable—a discovery that could revolutionize cancer treatment. Using ...

A team that includes a RIKEN researcher has refined a lab test for measuring protein aggregate levels in samples from patients with certain neurodegenerative diseases. This has the potential to ...

BU Target Discovery & Proteomics Laboratory (BU-TDPL), Boston University, Boston, Massachusetts 02215, United States Department of Chemistry, Boston University, Boston, Massachusetts 02215, United ...

A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.